< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 6 sources · 20 days · First seen · Last updated

Daewoong Pharmaceutical glucose management initiatives

Overview

Daewoong Pharmaceutical has expanded its involvement in blood glucose management through public health initiatives and professional medical education.

In late August, the company was selected as a partner for the Seoul Metropolitan Government’s ‘Blood Glucose Catch 9988’ project. This program targets 1,000 pre-diabetic citizens, providing them with continuous glucose monitoring (CGM) devices and lifestyle management services via the ‘Welda’ platform to encourage healthy habits.

Following this, in mid-September, Daewoong Pharmaceutical announced a web symposium titled ‘Shift in Blood Glucose Management Paradigm.’ The event brings together medical experts from South Korea and Japan to discuss clinical trends in CGM technology. The symposium focuses on ‘behavior change,’ emphasizing how continuous glucose data can help patients make daily adjustments to diet, exercise, and medication adherence.

Entities

Daewoong Pharmaceutical · Choi Seong-hee · Min Se-hee · Tokyo Women's Medical University · Mototsugu Nagao

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. [HEALTH] 5 sources
    Daewoong Pharmaceutical to host symposium on CGM-based diabetes management

    Daewoong Pharmaceutical is hosting a web symposium on the 16th featuring Korean and Japanese experts to discuss the latest trends in diabetes management using Continuous Glucose Monitoring (CGM).

  2. [HEALTH] 2 sources
    Daewoong Pharmaceutical to support Seoul blood glucose management project

    Daewoong Pharmaceutical will partner with the Seoul Metropolitan Government to provide continuous glucose monitoring and lifestyle management services to 1,000 pre-diabetic citizens.

Sources

biotimes.co.kr · bokuennews.com · bosa.co.kr · healthmedia.co.kr · sportschosun.com · thebionews.net